Cargando…
Elevation of sulfatides in ovarian cancer: An integrated transcriptomic and lipidomic analysis including tissue-imaging mass spectrometry
BACKGROUND: Sulfatides (ST) are a category of sulfated galactosylceramides (GalCer) that are elevated in many types of cancer including, possibly, ovarian cancer. Previous evidence for elevation of ST in ovarian cancer was based on a colorimetric reagent that does not provide structural details and...
Autores principales: | , , , , , , , , , , |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2010
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2913985/ https://www.ncbi.nlm.nih.gov/pubmed/20624317 http://dx.doi.org/10.1186/1476-4598-9-186 |
_version_ | 1782184717832945664 |
---|---|
author | Liu, Ying Chen, Yanfeng Momin, Amin Shaner, Rebecca Wang, Elaine Bowen, Nathan J Matyunina, Lilya V Walker, L DeEtte McDonald, John F Sullards, M Cameron Merrill, Alfred H |
author_facet | Liu, Ying Chen, Yanfeng Momin, Amin Shaner, Rebecca Wang, Elaine Bowen, Nathan J Matyunina, Lilya V Walker, L DeEtte McDonald, John F Sullards, M Cameron Merrill, Alfred H |
author_sort | Liu, Ying |
collection | PubMed |
description | BACKGROUND: Sulfatides (ST) are a category of sulfated galactosylceramides (GalCer) that are elevated in many types of cancer including, possibly, ovarian cancer. Previous evidence for elevation of ST in ovarian cancer was based on a colorimetric reagent that does not provide structural details and can also react with other lipids. Therefore, this study utilized mass spectrometry for a structure-specific and quantitative analysis of the types, amounts, and tissue localization of ST in ovarian cancer, and combined these findings with analysis of mRNAs for the relevant enzymes of ST metabolism to explore possible mechanisms. RESULTS: Analysis of 12 ovarian tissues graded as histologically normal or having epithelial ovarian tumors by liquid chromatography electrospray ionization-tandem mass spectrometry (LC ESI-MS/MS) established that most tumor-bearing tissues have higher amounts of ST. Because ovarian cancer tissues are comprised of many different cell types, histological tissue slices were analyzed by matrix-assisted laser desorption ionization-tissue-imaging MS (MALDI-TIMS). The regions where ST were detected by MALDI-TIMS overlapped with the ovarian epithelial carcinoma as identified by H & E staining and histological scoring. Furthermore, the structures for the most prevalent species observed via MALDI-TIMS (d18:1/C16:0-, d18:1/C24:1- and d18:1/C24:0-ST) were confirmed by MALDI-TIMS/MS, whereas, a neighboring ion(m/z 885.6) that was not tumor specific was identified as a phosphatidylinositol. Microarray analysis of mRNAs collected using laser capture microdissection revealed that expression of GalCer synthase and Gal3ST1 (3'-phosphoadenosine-5'-phosphosulfate:GalCer sulfotransferase) were approximately 11- and 3.5-fold higher, respectively, in the ovarian epithelial carcinoma cells versus normal ovarian stromal tissue, and they were 5- and 2.3-fold higher in comparison with normal surface ovarian epithelial cells, which is a likely explanation for the higher ST. CONCLUSIONS: This study combined transcriptomic and lipidomic approaches to establish that sulfatides are elevated in ovarian cancer and should be evaluated further as factors that might be important in ovarian cancer biology and, possibly, as biomarkers. |
format | Text |
id | pubmed-2913985 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2010 |
publisher | BioMed Central |
record_format | MEDLINE/PubMed |
spelling | pubmed-29139852010-08-03 Elevation of sulfatides in ovarian cancer: An integrated transcriptomic and lipidomic analysis including tissue-imaging mass spectrometry Liu, Ying Chen, Yanfeng Momin, Amin Shaner, Rebecca Wang, Elaine Bowen, Nathan J Matyunina, Lilya V Walker, L DeEtte McDonald, John F Sullards, M Cameron Merrill, Alfred H Mol Cancer Research BACKGROUND: Sulfatides (ST) are a category of sulfated galactosylceramides (GalCer) that are elevated in many types of cancer including, possibly, ovarian cancer. Previous evidence for elevation of ST in ovarian cancer was based on a colorimetric reagent that does not provide structural details and can also react with other lipids. Therefore, this study utilized mass spectrometry for a structure-specific and quantitative analysis of the types, amounts, and tissue localization of ST in ovarian cancer, and combined these findings with analysis of mRNAs for the relevant enzymes of ST metabolism to explore possible mechanisms. RESULTS: Analysis of 12 ovarian tissues graded as histologically normal or having epithelial ovarian tumors by liquid chromatography electrospray ionization-tandem mass spectrometry (LC ESI-MS/MS) established that most tumor-bearing tissues have higher amounts of ST. Because ovarian cancer tissues are comprised of many different cell types, histological tissue slices were analyzed by matrix-assisted laser desorption ionization-tissue-imaging MS (MALDI-TIMS). The regions where ST were detected by MALDI-TIMS overlapped with the ovarian epithelial carcinoma as identified by H & E staining and histological scoring. Furthermore, the structures for the most prevalent species observed via MALDI-TIMS (d18:1/C16:0-, d18:1/C24:1- and d18:1/C24:0-ST) were confirmed by MALDI-TIMS/MS, whereas, a neighboring ion(m/z 885.6) that was not tumor specific was identified as a phosphatidylinositol. Microarray analysis of mRNAs collected using laser capture microdissection revealed that expression of GalCer synthase and Gal3ST1 (3'-phosphoadenosine-5'-phosphosulfate:GalCer sulfotransferase) were approximately 11- and 3.5-fold higher, respectively, in the ovarian epithelial carcinoma cells versus normal ovarian stromal tissue, and they were 5- and 2.3-fold higher in comparison with normal surface ovarian epithelial cells, which is a likely explanation for the higher ST. CONCLUSIONS: This study combined transcriptomic and lipidomic approaches to establish that sulfatides are elevated in ovarian cancer and should be evaluated further as factors that might be important in ovarian cancer biology and, possibly, as biomarkers. BioMed Central 2010-07-12 /pmc/articles/PMC2913985/ /pubmed/20624317 http://dx.doi.org/10.1186/1476-4598-9-186 Text en Copyright ©2010 Liu et al; licensee BioMed Central Ltd. http://creativecommons.org/licenses/by/2.0 This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. |
spellingShingle | Research Liu, Ying Chen, Yanfeng Momin, Amin Shaner, Rebecca Wang, Elaine Bowen, Nathan J Matyunina, Lilya V Walker, L DeEtte McDonald, John F Sullards, M Cameron Merrill, Alfred H Elevation of sulfatides in ovarian cancer: An integrated transcriptomic and lipidomic analysis including tissue-imaging mass spectrometry |
title | Elevation of sulfatides in ovarian cancer: An integrated transcriptomic and lipidomic analysis including tissue-imaging mass spectrometry |
title_full | Elevation of sulfatides in ovarian cancer: An integrated transcriptomic and lipidomic analysis including tissue-imaging mass spectrometry |
title_fullStr | Elevation of sulfatides in ovarian cancer: An integrated transcriptomic and lipidomic analysis including tissue-imaging mass spectrometry |
title_full_unstemmed | Elevation of sulfatides in ovarian cancer: An integrated transcriptomic and lipidomic analysis including tissue-imaging mass spectrometry |
title_short | Elevation of sulfatides in ovarian cancer: An integrated transcriptomic and lipidomic analysis including tissue-imaging mass spectrometry |
title_sort | elevation of sulfatides in ovarian cancer: an integrated transcriptomic and lipidomic analysis including tissue-imaging mass spectrometry |
topic | Research |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2913985/ https://www.ncbi.nlm.nih.gov/pubmed/20624317 http://dx.doi.org/10.1186/1476-4598-9-186 |
work_keys_str_mv | AT liuying elevationofsulfatidesinovariancanceranintegratedtranscriptomicandlipidomicanalysisincludingtissueimagingmassspectrometry AT chenyanfeng elevationofsulfatidesinovariancanceranintegratedtranscriptomicandlipidomicanalysisincludingtissueimagingmassspectrometry AT mominamin elevationofsulfatidesinovariancanceranintegratedtranscriptomicandlipidomicanalysisincludingtissueimagingmassspectrometry AT shanerrebecca elevationofsulfatidesinovariancanceranintegratedtranscriptomicandlipidomicanalysisincludingtissueimagingmassspectrometry AT wangelaine elevationofsulfatidesinovariancanceranintegratedtranscriptomicandlipidomicanalysisincludingtissueimagingmassspectrometry AT bowennathanj elevationofsulfatidesinovariancanceranintegratedtranscriptomicandlipidomicanalysisincludingtissueimagingmassspectrometry AT matyuninalilyav elevationofsulfatidesinovariancanceranintegratedtranscriptomicandlipidomicanalysisincludingtissueimagingmassspectrometry AT walkerldeette elevationofsulfatidesinovariancanceranintegratedtranscriptomicandlipidomicanalysisincludingtissueimagingmassspectrometry AT mcdonaldjohnf elevationofsulfatidesinovariancanceranintegratedtranscriptomicandlipidomicanalysisincludingtissueimagingmassspectrometry AT sullardsmcameron elevationofsulfatidesinovariancanceranintegratedtranscriptomicandlipidomicanalysisincludingtissueimagingmassspectrometry AT merrillalfredh elevationofsulfatidesinovariancanceranintegratedtranscriptomicandlipidomicanalysisincludingtissueimagingmassspectrometry |